Nevro Corp (1N7.BE)
| Previous close | 9.40 |
| Open | 9.70 |
| Bid | 9.05 x N/A |
| Ask | 9.10 x N/A |
| Day's range | 9.70 - 9.70 |
| 52-week range | 9.40 - 26.20 |
| Volume | |
| Avg. volume | 0 |
| Market cap | N/A |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | 30 July 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
Simply Wall St.Earnings Release: Here's Why Analysts Cut Their Nevro Corp. (NYSE:NVRO) Price Target To US$15.30
Nevro Corp. ( NYSE:NVRO ) investors will be delighted, with the company turning in some strong numbers with its latest...
PR NewswireNevro to Present at BofA Securities 2024 Healthcare Conference
Nevro Corp. (NYSE: NVRO), a global medical device company that is delivering comprehensive, life-changing solutions for the treatment of chronic pain, today announced that members of its management team will participate in the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, 2024. The company's formal presentation will begin at 9:20 am PDT (12:20 am EDT).
Insider MonkeyNevro Corp. (NYSE:NVRO) Q1 2024 Earnings Call Transcript
Nevro Corp. (NYSE:NVRO) Q1 2024 Earnings Call Transcript May 8, 2024 Nevro Corp. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good afternoon. My name is Audra, and I will be your conference operator today. At this time, I would […]
